Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
NightstaRx
Biotech
Biogen-Nightstar deal sheds light on gene therapy feeding frenzy
The level of interest in gene therapies has been laid bare by a report on Biogen’s pursuit of Nightstar Therapeutics.
Nick Paul Taylor
Mar 19, 2019 9:27am
Biogen strikes $877M Nightstar gene therapy buyout
Mar 4, 2019 10:06am
Nightstar posts early-phase data on retinal gene therapy
Sep 24, 2018 10:30am
Cancer, gene therapy biotechs raise $303M in IPO bonanza
Sep 28, 2017 3:53am
EuroBiotech Report—Cellectis, NuCana, Nightstar, Destiny and Verona
Sep 7, 2017 2:36pm
Nightstar files for $86M IPO to fund gene therapy trials
Sep 1, 2017 8:02am
